Clinical Trial Update: A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) [Phase 3]

View source ↗

Summary

Phase 3 study of Aticaprant for major depressive disorder has been terminated, according to the trial record.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Aticaprant (Aticaprant)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major | Phase 3 | Status: TERMINATED